Carregando...
Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
Cetuximab is a monoclonal antibody able to inhibit and to degrade the transmembrane receptor Her-1, also known as epidermal growth factor receptor (EGFR). The inhibition of EGFR is of major importance since the receptor influences many important tumor cell activities including tumor growth, neo-angi...
Na minha lista:
Principais autores: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2007
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376084/ https://ncbi.nlm.nih.gov/pubmed/18473010 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|